Lupin launches generic GERD drug in the US market

Drug major Lupin said on Monday it has launched a generic version of Japan-headquartered Eisai Inc's Aciphex delayed-release tablets, used to treat gastroesophageal reflux disease, in the US......

Dr Reddy's launch generic cancer drug in US market

Drug firm Dr Reddy's Laboratories said on Friday it has launched its generic Decitabine injection used in treatment of cancer in the American market after receiving approval from the US health......

It's destination India for Japan Inc!

India has become the most sought destination for investment by Japanese companies, next to China, and ahead of other Asian countries and emerging economies like Russia, Brazil, Mexico and even the......

Drug firms eye Japan market

Japan, the world's third largest and one of the most regulated pharmaceutical markets globally, is emerging as the new attractive destination for Indian drug majors. The $60 billion Japanese pharma......